IP Library Granted Patent US 10,500,030
Granted Patent B2
US 10,500,030 · App. 15/214,209 · Granted Dec 10, 2019

Surgical attachment device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,500,030
App. No.
15/214,209
Granted
Dec 10, 2019
Kind
B2
Abstract

A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.

Claims (27)

1. A method for using a surgical attachment device comprising:

forming the surgical attachment device, wherein forming comprises stitching at least a length of a first leader through a biologic sheet, wherein the first leader comprises a first synthetic material, and wherein the stitching comprises extending at least a length of the first leader from a first edge of the biological sheet across the biological sheet to a second edge of the biological sheet, and across the biological sheet to the first edge of the biological sheet;

inserting a breast implant into a patient;

attaching the surgical attachment device adjacent to the breast implant, wherein the surgical attachment device has a first post-implantation configuration and a second post-implantation configuration, wherein when the surgical attachment device is in the first post-implantation configuration, the first leader exerts a first resistive force, wherein when the surgical attachment device is in the second post-implantation configuration, the first leader exerts a second resistive force, and wherein the first resistive force is less than the second resistive force.

2. The device of claim 1 , wherein the first synthetic material comprises a non-biodegradable polymer.

3. The method of claim 1 , further comprising stitching a second leader through the surgical attachment device.

4. The method of claim 3 , wherein the second leader comprises a second synthetic material.

5. The method of claim 4 , wherein the first synthetic material has the same type of material as the second synthetic material.

6. The method of claim 3 , wherein the second leader intersects the first leader.

7. The method of claim 3 , wherein the second leader extends from a first edge to a second edge of the surgical attachment device.

8. The method of claim 1 , wherein at least a length of the first leader has a zig-zag shape.

9. The method of claim 1 , wherein at least a length of the first leader has a sinusoidal shape.

10. The method of claim 1 , wherein the surgical attachment device comprises collagen.

11. The method of claim 1 , wherein the surgical attachment device comprises a first layer and a second layer.

12. The method of claim 1 , wherein the first leader comprises a monofilament.

13. The method of claim 1 , wherein the forming further comprises cutting a shape of the surgical attachment device out of a biologic sheet.

14. The method of claim 13 , wherein the cutting comprises cutting the first leader.

15. The method of claim 1 , wherein the forming of the attachment device further comprises bonding a first layer to a second layer.

16. A method for using a surgical attachment device comprising:

forming the surgical attachment device, wherein forming comprises stitching at least a length of a first leader through a biologic sheet, wherein the first leader comprises a synthetic material, wherein the stitching comprises extending at least a length of the first leader from a first edge of the surgical attachment device across the surgical attachment device to a second edge of the surgical attachment device, and across the surgical attachment device to the first edge of the surgical attachment device;

inserting an implant into a target site, wherein at least part of the target site is in a breast;

inserting the surgical attachment device into the target site, wherein the surgical attachment device has a first stretched configuration and a second stretched configuration, wherein when the surgical attachment device is in the first stretched configuration, the first leader exerts a first resistive force, wherein when the surgical attachment device is in the second stretched configuration, the first leader exerts a second resistive force, and wherein the second resistive force is more than the first resistive force.

17. The method of claim 16 , wherein the inserting of the implant comprises positioning the implant under the pectoralis major muscle.

18. The method of claim 16 , further comprising attaching the surgical attachment device to soft and/or hard tissue adjacent to the implant.

19. A method for using an implantable support device comprising:

inserting a support device into a target site, wherein at least part of the target site is in a breast, and wherein the support device comprises at least a length of a first leader stitched through a biological sheet, wherein at least a length of the first leader extends from a first edge of the biological sheet across the biological sheet to a second edge of the biological sheet, and across the biological sheet to the first edge of the biological sheet, wherein the first leader comprises a synthetic material, and wherein the biological sheet comprises a first layer bonded to a second layer, wherein the support device has a first post-implantation configuration and a second post-implantation configuration, wherein the biological sheet is stretched more in the second post-implantation configuration than in the first post-implantation configuration, and wherein the first leader is strained more in the second post-implantation configuration than in the first post-implantation configuration.

20. The method of claim 1 , further comprising removing antigenic compounds from at least part of the biological sheet.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2025
From: MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 072912/0103 →
SECURITY INTEREST Recorded Nov 14, 2025
From: TELA BIO, INC.
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 072905/0537 →
RELEASE OF SECURITY INTEREST Recorded Aug 24, 2022
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: TELA BIO, INC.
Reel/Frame 060888/0585 →
SECURITY INTEREST Recorded Aug 24, 2022
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060888/0633 →
RELEASE OF SECURITY INTEREST Recorded Aug 15, 2019
From: HERCULES CAPITAL, INC.
To: TELA BIO, INC.
Reel/Frame 050061/0654 →
RELEASE OF SECURITY INTEREST (TERM) Recorded Nov 16, 2018
From: MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 047587/0033 →
SECURITY INTEREST Recorded Nov 16, 2018
From: TELA BIO, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 047526/0281 →
RELEASE OF SECURITY INTEREST (REVOLVING) Recorded Nov 16, 2018
From: MIDCAP FUNDING IV TRUST, AS SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 047586/0986 →
SECURITY INTEREST (REVOLVER) Recorded Apr 27, 2018
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046026/0680 →
SECURITY INTEREST (TERM) Recorded Apr 27, 2018
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046026/0749 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2018
From: ORBIMED PRIVATE INVESTMENTS IV, LP
To: TELA BIO, INC.
Reel/Frame 045630/0510 →
SECURITY INTEREST Recorded Apr 4, 2017
From: TELA BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 041849/0154 →
SECURITY INTEREST Recorded Jan 25, 2017
From: TELA BIO, INC.
To: ORBIMED PRIVATE INVESTMENTS IV, LP
Reel/Frame 041082/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2016
From: GREENHALGH, E. SKOTT; ROMANO, JOHN-PAUL
To: TELA BIO, INC.
Reel/Frame 039192/0155 →